What happened
Boditech Med filed provisional (unaudited) consolidated results for Q2 2026: revenue of US$35.5M (+21.54% year on year), operating profit of US$5.8M (−10.45% year on year) and net income of US$5.21M (−0.7% year on year).
These are preliminary figures the company disclosed ahead of its audited report; the final numbers can differ.
| Revenue | US$35.5M |
|---|---|
| Revenue vs a year earlier | +21.54% |
| Operating profit | US$5.8M |
| Net income | US$5.21M |
| Period | Q2 2026 (consolidated) |
| Filed | 2026-07-30, Operating results (consolidated) (preliminary) (fair disclosure) |
| Source | DART rcept 20260730900343 → open original filing |
Source: DART. Information only, not investment advice.